ZimVie Inc (NAS:ZIMV)
$ 16.26 0.05 (0.31%) Market Cap: 448.32 Mil Enterprise Value: 618.09 Mil PE Ratio: 0 PB Ratio: 1.14 GF Score: 25/100

ZimVie Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 11:00PM GMT
Release Date Price: $8.78 (+3.78%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Good afternoon, everyone. Welcome. I'm Robbie Marcus, the med tech analyst at JPMorgan. Very happy to host ZimVie for our next session. I'm going to bring up President and CEO, Vafa Jamali, and then we'll do some Q&A afterwards. Vafa?

Vafa Jamali
ZimVie Inc. - President, CEO & Director

Thanks, Robbie. Thanks very much. Very, very happy to be here. I'm Vafa Jamali, and I'd like to tell you a little bit about ZimVie, who we are and a little bit about what we're focused on and what the future looks like and why you should be excited to watch our progress. So this disclaimer, I'll allow you to read this on your own.

Really, when we started this company, we spun off of a company called Zimmer Biomet on March 1, 2022. So we've been independent for about 9 months. And we set out to have a vision. Our vision was everyone deserves to feel better, healthier and stronger, and we create solutions for people to enjoy and experience life. Our mission is to advance clinical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot